Education
About Us
Working with TipRanks
Follow Us
John E. Bishop Insider Profile
4 Followers
John E. Bishop, SVP, Pharmaceutical Scie at Momenta Pharma, holds 339.15K shares in Ardelyx (Ticker: ARDX), holds 0.00 shares in Forma Therapeutics Holdings (Ticker: FMTX), holds 93.52K shares in Momenta Pharma (Ticker: MNTA). Most recently, John E. Bishop Sold ― shares of Ardelyx on Feb 23, 2026 for an estimated value of $18.57K.
John E. Bishop Momenta Pharma (MNTA)SVP, Pharmaceutical Scie
Momenta Pharma (MNTA)
SVP, Pharmaceutical Scie
Ranked #60,319 out of 106,324 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-7.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John E. Bishop holds in companies
Most Profitable Insider Trade
Stock:
Momenta Pharma
(MNTA)
(MNTA)
Rating:Informative Sell
Date:Aug 30, 2012 - Aug 30, 2013
Return:+0.90%
The most profitable trade made by John E. Bishop
John E. Bishop's Trading History
Momenta Pharma
May 23, 2016
―
Uninformative Sell
8.00K
$4.91M
Forma Therapeutics Holdings
Oct 14, 2022
―
Uninformative Sell
―
$0.00
Lyra Therapeutics
―
CTO
―
―
Ardelyx
Feb 23, 2026
Chief Technical Operations Officer
Informative Sell
18.57K
$2.03M
List of latest transactions for each holding click on a transaction to see John E. Bishop's performance on stock
You May Also Like
John E. Bishop insider profile FAQ
What is the percentage of profitable transactions made by John E. Bishop?
The percentage of profitable transactions made by John E. Bishop is 50%.
What is the average return per transaction made by John E. Bishop?
The average return per transaction made by John E. Bishop is -7.10%.
What stocks does John E. Bishop hold?
John E. Bishop holds: MNTA, FMTX, LYRA, ARDX stocks.
What was John E. Bishop’s latest transaction?
John E. Bishop latest transaction was an Informative Sell of $18.57K.
What was John E. Bishop's most profitable transaction?
John E. Bishop’s most profitable transaction was an Informative Sell of MNTA stock on August 30, 2012. The return on the trade was 0.90%.
What is John E. Bishop's role in Momenta Pharma?
John E. Bishop's role in Momenta Pharma is SVP, Pharmaceutical Scie.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.